Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: LoLoLoLita who wrote (6780)	4/10/1998 3:41:00 AM
From: VLAD	Read Replies (2) \| Respond to of 23519

David, The amount of cash on hand has absolutely no effect on earnings. Earnings are based on income for the quarter minus expenses. If they are sitting on $40 million cash or $140 million it will not impact the earnings numbers.

To: LoLoLoLita who wrote (6780)	4/10/1998 11:25:00 AM
From: blankmind	Read Replies (1) \| Respond to of 23519

- VVUS still has an enviable $40+ mill in the bank. No need to take on debt. Their operations, if no more stock buybacks & legal settlements; and plant buildouts, etc ... will actually increase their cash on hand during the 2nd and following quarters. - As a stockholder - a stock buyback is the #1 thing to do with excess cash. Any underwriter will gladly do a 2ndry for Vivus. - Vivus could even probably secure a $50mill + line of credit. - I'm actually happy with everything except the stock price. Which I learned long ago to mean stick with it. Be patient.